Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.315 EUR
74.08 M EUR
275.65 M EUR
44.54 M
About Galapagos NV
Sector
Industry
CEO
Henry O. Gosebruch
Website
Headquarters
Mechelen
Founded
1999
ISIN
BE0003818359
FIGI
BBG000GD4QH3
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Related stocks
Galapagos to break below 7 year low?Galapagos - Intraday - We look to Sell a break of 40.98 (stop at 43.03)
Daily signals are bearish.
There is no clear indication that the downward move is coming to an end.
Trades at the lowest level in 38 weeks.
The previous low is located at 41.30.
A break of 41.00 is needed to confirm follow
Galapagos (GLPG.as) bearish scenario:The technical figure Triangle can be found in the Belgium company Galapagos NV (GLPG.as) at daily chart. Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. The company develops drugs against rheumatoid arthritis, Crohn's diseas
GLPG.BR completing 3rd wave up off the Dec lowTLDR: targeting 80 if next pull back holds 56.
--
Galapagos has gained more than 50% nominally off the Dec '21 low, in a three waves structure.
While running into the 1.618 extension of the green circle i-ii, the technicals are becoming overbought.
With the next earning report within a month, it se
Careful LONG GLPGI've been following this tock for quit some time. Seeing it fall and many people calling to go LONG, only to fall even further. The cash position alone equals 80 share price. Fundamental Mumbo Jumbo. The chart had much more downside to go.
Now we have a potential bottom forming. The RSI is oversold
GLPG high R:R speculative play not for the faint-heartedConclusion
If current retracement levels hold and subsequently break above 74, bull case targeting 400+ is in play.
First indication of upside would be recovering 60.
Technical
Nominally dropped over 80% sinds the wave 3 top in 2020, while volume profile suggests uphill battle toward 60 is tough.
Galapagos is it time to buy ? DYOR NFAHealthcare has been getting slapped as of late but there are some fine investment opportunities. Galapagos is one I have been keeping an eye on. It has formed a broadening wedge on the long term and holding nicely on the support line. Fisher on the monthly frame has crossed up and MACD is showing si
Galapagos breaking out various falling wedge patterns today!Galapagos springt uit zijn meer dan een jaar oude dalende wig. Volume vandaag geeft aan dat kopers de overhand gaan krijgen. Bevestiging zou moeten komen van nog een stevige candlestick en mogelijk openingskoers met een gap tot boven de MA50!
Galapagos broke out of its one year(+) old falling wegde
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Galapagos NV stocks are traded under the ticker GXE.
We've gathered analysts' opinions on Galapagos NV future price: according to them, GXE price has a max estimate of 44.80 EUR and a min estimate of 18.70 EUR. Watch GXE chart and read a more detailed Galapagos NV stock forecast: see what analysts think of Galapagos NV and suggest that you do with its stocks.
Yes, you can track Galapagos NV financials in yearly and quarterly reports right on TradingView.
Galapagos NV is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
GXE earnings for the last quarter are −1.58 EUR per share, whereas the estimation was −0.20 EUR resulting in a −692.70% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about Galapagos NV earnings.
Galapagos NV revenue for the last quarter amounts to 65.29 M EUR, despite the estimated figure of 69.99 M EUR. In the next quarter, revenue is expected to reach 67.96 M EUR.
GXE net income for the last quarter is −105.75 M EUR, while the quarter before that showed −153.40 M EUR of net income which accounts for 31.07% change. Track more Galapagos NV financial stats to get the full picture.
No, GXE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 4, 2025, the company has 704 employees. See our rating of the largest employees — is Galapagos NV on this list?
Like other stocks, GXE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galapagos NV stock right from TradingView charts — choose your broker and connect to your account.